(MENAFN- GlobeNewsWire - Nasdaq) SNS Insider's new report reveals that the U.S. Fecal Calprotectin Testing market, valued at USD 1.31 billion in 2023, will grow at a CAGR of 11.7% through 2032 amid ...
Fecal calprotectin is a highly sensitive assay that measures inflammation present in the intestinal tract. Gastroenterologists are increasingly ordering fecal calprotectin to screen and monitor ...
Jersey doctors could be able to send patients for a test to check for inflammatory bowel disease (IBD) later this year. The ...
SALEM, N.H., May 8, 2025 /PRNewswire/ -- American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, announced the European commercial launch of its ...
SAN DIEGO, Feb. 23, 2021 /PRNewswire/ -- ProciseDx Inc. announced today that it has received CE mark for its Fecal Calprotectin (Procise FCP™) point of care tests for use on the ProciseDx™ system.
High levels of calprotectin indicate IBD, while low or normal levels indicate IBS. In the United States, an estimated 3.1 million adults have been diagnosed with IBD. Currently, fecal calprotectin ...
BÜHLMANN, a company based in Germany, launched IBDoc, an at-home, in-vitro diagnostic test for gastrointestinal conditions, including some inflammatory bowel diseases, according to an IBD News Today ...
Please provide your email address to receive an email when new articles are posted on . In a prospective study, researchers enrolled 457 asymptomatic participants (mean age 61.4 years; 75% women) from ...
A TEST that can distinguish between inflammatory and non-inflammatory bowel diseases will be made available to Jersey GPs before the end of the year – over a decade after it was approved for use in UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback